A blocking peptide containing 19 amino acids near the extracellular domain of human DR3.
Points forts
Source
Synthetic
(Accession #: AAQ88676) The DR3/TNFRSF25 Blocking Peptide has been validated for the following applications: Antibody Competition.
Caractéristiques techniques
| Marque | Novus Biologicals |
|---|
| Réf. B-LABO | BL-RE-104017 |
|---|
| Réf. fabricant | 18270026 |
|---|
| Gene ID (Entrez) | 8718 |
|---|
| Espèces | Human |
|---|
| Contenu et stockage | Store at -20 C. Avoid freeze-thaw cycles. |
|---|
| Formule | PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin. |
|---|
| À utiliser avec (application) | This Peptide is Useful as a Blocking Peptide for NBP1-77019. For Further Blocking Peptide Related Protocol, Click Here . |
|---|
| Alias de gène | Apo-3, APO3, Apoptosis-inducing receptor AIR, Apoptosis-mediating receptor DR3, Apoptosis-mediating receptor TRAMP, Death receptor 3, DR3member 12 (translocatingchain-association membrane protein), Lymphocyte-associated receptor of death, Protein WSL, Protein WSL-1, tumor necrosis factor receptor superfamily, member 25, WSL, WSL1 |
|---|
| Symbole de gène(s) | TNFRSF25 |
|---|
| Type de produit | DR3/TNFRSF25 |
|---|
| Quantité | 0.05 mg |
|---|
| État réglementaire | RUO - research use only |
|---|
| Source | Synthetic |
|---|
| Consigne | 19 amino acids near the extracellular domain of human DR3 |
|---|
Une question, une configuration particulière ?
Contactez-nous pour un devis.
